BMJ  2005;330:1382-1384 (11 June), doi:10.1136/bmj.330.7504.1382

Education and debate

Prognosis without treatment as a modifier in health economic assessments

Ross Camidge, clinical lecturer in cancer therapeutics1, Andrew Walker, senior lecturer in health economics2, James J Oliver, clinical lecturer in clinical pharmacology and therapeutics1, Fiona Nussey, clinical lecturer in medical oncology3, Simon Maxwell, senior lecturer in clinical pharmacology and therapeutics1, Duncan Jodrell, reader in oncology3, David J Webb, professor of clinical pharmacology and therapeutics1

1 Clinical Pharmacology Unit, Western General Hospital, Edinburgh EH4 2XU, 2 Robertson Centre for Biostatistics, University of Glasgow, Glasgow G12 8QQ, 3 Edinburgh Cancer Centre, Western General Hospital

Correspondence to: R Camidge drcamidge@talk21.com

How long someone has to live intuitively seems important in rationing decisions. Incorporating it into economic assessments, as described here, could make decisions fairer

The first 150 words of the full text of this article appear below.

Introduction

Explicit rationing—decisions not to fund certain treatments—has become a fact of life in many healthcare systems.1-4 Health economic assessments often underpin rationing decisions, although it remains unclear whether society's values are well reflected by the utilitarian approach of maximising the units of health attainable from available resources.5 6 Health economic assessments are used to determine the additional cost per unit of health gain for different treatment options. Cost effectiveness analysis is the most common method of assessment7 8 and, for life shortening conditions, primarily focuses on the additional cost per life year gained. We propose that prognosis without treatment is an important contextual modifier of life years gained in evaluating treatments for life shortening conditions. We present initial data supporting this hypothesis and describe resource allocation strategies that use this information.

Limitations of life years gained

Life years gained represent the extra life expectancy resulting from a treatment. By definition, the comparison is with the life expectancy . . . [Full text of this article]

QALYs and contextual modifiers

Evidence for use of prognosis without treatment

What further work is required?


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

A middle way for rationing healthcare resources
Rudolf Klein
BMJ 2005 330: 1340-1341. [Extract] [Full Text] [PDF]

Is economic evaluation in touch with society's health values?
Joanna Coast
BMJ 2004 329: 1233-1236. [Extract] [Full Text] [PDF]

National Institute for Clinical Excellence and its value judgments
Michael D Rawlins and Anthony J Culyer
BMJ 2004 329: 224-227. [Extract] [Full Text] [PDF]

Challenges for the National Institute for Clinical Excellence
Alan Maynard, Karen Bloor, and Nick Freemantle
BMJ 2004 329: 227-229. [Extract] [Full Text] [PDF]

The rationing debate: Rationing health care by age: The case for
Alan Williams
BMJ 1997 314: 820. [Extract] [Full Text]

The rationing debate: Rationing health care by age: The case against
J Grimley Evans
BMJ 1997 314: 822. [Extract] [Full Text]

This article has been cited by other articles:

  • Klein, R. (2005). A middle way for rationing healthcare resources. BMJ 330: 1340-1341 [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ